Mandatory tumor biopsies at screening for ovarian cancer patients will be required for patient enrollment to the MTD dose expansion cohort. Optional on-treatment biopsies will be requested from consenting patients in the ovarian expansion phase cohort (Cycle 1 between Day 8 and Day 21).